FDA.reportPublic FDA data

National Council for Prescription Drug Programs indexing - billing unit

Manufacturer
National Council for Prescription Drug Programs
Effective date
2012-07-24
Label type
Indexing - Billing Unit
Version
1
Source
full-release
Hydrated at
2026-06-05 01:05:39

Label at a glance#

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
61314-641-75ML - Milliliter61314-641078a5019-53ee-457c-a00a-e01ef44f7bb012012-07-24

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
61314-64161314-641-75

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A062874-001NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONEHYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE1%;EQ 3.5MG BASE/ML;10,000 UNITS/MLSUSPENSION/DROPS / OPHTHALMICRS1988-05-11

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 2 of 2 · 44 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2022-10-28 04:53 UTC2022-10A062874-001NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE1%;EQ 3.5MG BASE/ML;10,000 UNITS/MLSUSPENSION/DROPS / OPHTHALMICRS1988-05-11f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A062874-001NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE1%;EQ 3.5MG BASE/ML;10,000 UNITS/MLSUSPENSION/DROPS / OPHTHALMICRS1988-05-11e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A062874-001NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE1%;EQ 3.5MG BASE/ML;10,000 UNITS/MLSUSPENSION/DROPS / OPHTHALMICRS1988-05-11cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A062874-001NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE1%;EQ 3.5MG BASE/ML;10,000 UNITS/MLSUSPENSION/DROPS / OPHTHALMICRS1988-05-11a50c72e98297…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Neomycin and Polymyxin B Sulfates and HydrocortisoneNEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONESandoz Inc96a7b0a5-030a-42dc-80cd-35c4e9aa1b6d2021-08-31Warnings, Adverse reactionsExact identifier
ndc (package): 61314-641-75
ndc11 (package): 61314064175

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.